annual current liabilities:
$27.23B+$386.65M(+1.44%)Summary
- As of today (August 20, 2025), GSK annual total current liabilities is $27.23 billion, with the most recent change of +$386.65 million (+1.44%) on December 31, 2024.
- During the last 3 years, GSK annual current liabilities has fallen by -$4.72 billion (-14.78%).
- GSK annual current liabilities is now -24.18% below its all-time high of $35.91 billion, reached on December 31, 2017.
Performance
GSK Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$27.92B+$1.04B(+3.86%)Summary
- As of today (August 20, 2025), GSK quarterly total current liabilities is $27.92 billion, with the most recent change of +$1.04 billion (+3.86%) on June 30, 2025.
- Over the past year, GSK quarterly current liabilities has increased by +$2.21 billion (+8.58%).
- GSK quarterly current liabilities is now -39.23% below its all-time high of $45.95 billion, reached on June 30, 2022.
Performance
GSK quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
GSK Current liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1.4% | +8.6% |
3 y3 years | -14.8% | -39.2% |
5 y5 years | -13.7% | -5.5% |
GSK Current liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -14.8% | +1.4% | -39.2% | +19.4% |
5 y | 5-year | -14.8% | +1.4% | -39.2% | +19.4% |
alltime | all time | -24.2% | +4815.1% | -39.2% | +3163.9% |
GSK Current liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $27.92B(+3.9%) |
Mar 2025 | - | $26.89B(-1.1%) |
Dec 2024 | $27.23B(+1.4%) | $27.17B(-5.6%) |
Sep 2024 | - | $28.78B(+11.9%) |
Jun 2024 | - | $25.72B(+2.6%) |
Mar 2024 | - | $25.07B(-6.7%) |
Dec 2023 | $26.84B(-2.8%) | $26.86B(-1.7%) |
Sep 2023 | - | $27.33B(-2.8%) |
Jun 2023 | - | $28.11B(+9.8%) |
Mar 2023 | - | $25.59B(-6.7%) |
Dec 2022 | $27.60B(-13.6%) | $27.44B(+17.3%) |
Sep 2022 | - | $23.39B(-49.1%) |
Jun 2022 | - | $45.95B(+53.0%) |
Mar 2022 | - | $30.03B(-6.3%) |
Dec 2021 | $31.95B(+5.8%) | $32.06B(+6.1%) |
Sep 2021 | - | $30.23B(+2.3%) |
Jun 2021 | - | $29.55B(+5.6%) |
Mar 2021 | - | $27.97B(-7.6%) |
Dec 2020 | $30.18B(-4.3%) | $30.28B(+5.6%) |
Sep 2020 | - | $28.67B(-3.0%) |
Jun 2020 | - | $29.56B(-5.9%) |
Mar 2020 | - | $31.41B(-1.4%) |
Dec 2019 | $31.53B(+10.5%) | $31.86B(+1.3%) |
Sep 2019 | - | $31.44B(-4.2%) |
Jun 2019 | - | $32.81B(+2.9%) |
Mar 2019 | - | $31.87B(+11.3%) |
Dec 2018 | $28.54B(-20.5%) | $28.64B(+19.4%) |
Sep 2018 | - | $23.99B(-0.2%) |
Jun 2018 | - | $24.03B(-36.4%) |
Mar 2018 | - | $37.77B(+5.1%) |
Dec 2017 | $35.91B(+53.8%) | $35.94B(-2.4%) |
Sep 2017 | - | $36.81B(-1.6%) |
Jun 2017 | - | $37.39B(+59.4%) |
Mar 2017 | - | $23.45B(-0.1%) |
Dec 2016 | $23.34B(+17.4%) | $23.48B(-0.3%) |
Sep 2016 | - | $23.56B(-2.7%) |
Jun 2016 | - | $24.21B(+21.0%) |
Mar 2016 | - | $20.01B(+1.2%) |
Dec 2015 | $19.88B(-3.9%) | $19.78B(+2.4%) |
Sep 2015 | - | $19.31B(-11.0%) |
Jun 2015 | - | $21.70B(-7.4%) |
Mar 2015 | - | $23.43B(+13.0%) |
Dec 2014 | $20.69B(-8.2%) | $20.73B(-16.3%) |
Sep 2014 | - | $24.75B(+18.2%) |
Jun 2014 | - | $20.95B(+7.7%) |
Mar 2014 | - | $19.45B(-14.1%) |
Dec 2013 | $22.55B(+1.0%) | $22.65B(+9.0%) |
Sep 2013 | - | $20.78B(+9.8%) |
Jun 2013 | - | $18.92B(+3.8%) |
Mar 2013 | - | $18.23B(-18.8%) |
Dec 2012 | $22.33B(-3.5%) | $22.46B(-0.4%) |
Sep 2012 | - | $22.55B(-6.7%) |
Jun 2012 | - | $24.16B(+4.0%) |
Mar 2012 | - | $23.22B(-0.5%) |
Dec 2011 | $23.13B(+17.1%) | $23.33B(+14.3%) |
Sep 2011 | - | $20.42B(-6.6%) |
Jun 2011 | - | $21.87B(+4.1%) |
Mar 2011 | - | $21.02B(+4.9%) |
Dec 2010 | $19.75B | $20.03B(+13.1%) |
Sep 2010 | - | $17.72B(-1.3%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2010 | - | $17.96B(-2.6%) |
Mar 2010 | - | $18.43B(-5.8%) |
Dec 2009 | $19.60B(+33.6%) | $19.57B(+10.0%) |
Sep 2009 | - | $17.78B(+19.5%) |
Jun 2009 | - | $14.88B(+6.5%) |
Mar 2009 | - | $13.97B(-3.0%) |
Dec 2008 | $14.67B(-28.7%) | $14.40B(-8.2%) |
Sep 2008 | - | $15.68B(-4.7%) |
Jun 2008 | - | $16.45B(-10.8%) |
Mar 2008 | - | $18.44B(-10.4%) |
Dec 2007 | $20.57B(+44.6%) | $20.59B(+11.9%) |
Sep 2007 | - | $18.40B(+27.2%) |
Jun 2007 | - | $14.46B(-0.9%) |
Mar 2007 | - | $14.60B(+2.7%) |
Dec 2006 | $14.22B(-13.0%) | $14.22B(+4.4%) |
Sep 2006 | - | $13.62B(-10.7%) |
Jun 2006 | - | $15.26B(-5.9%) |
Mar 2006 | - | $16.21B(-0.7%) |
Dec 2005 | $16.35B(+1.4%) | $16.33B(+2.3%) |
Sep 2005 | - | $15.96B(+1.9%) |
Jun 2005 | - | $15.66B(-11.9%) |
Mar 2005 | - | $17.77B(+8.1%) |
Dec 2004 | $16.13B(+5.1%) | $16.44B(+13.1%) |
Sep 2004 | - | $14.54B(-4.4%) |
Jun 2004 | - | $15.22B(-4.8%) |
Mar 2004 | - | $15.99B(+3.9%) |
Dec 2003 | $15.35B(+8.1%) | $15.39B(+9.2%) |
Sep 2003 | - | $14.09B(+6.2%) |
Jun 2003 | - | $13.27B(-1.0%) |
Mar 2003 | - | $13.40B(-5.5%) |
Dec 2002 | $14.20B(+3.7%) | $14.18B(+0.7%) |
Sep 2002 | - | $14.09B(+246.0%) |
Jun 2002 | - | $4.07B(-69.9%) |
Mar 2002 | - | $13.55B(-1.3%) |
Dec 2001 | $13.69B(+1.1%) | $13.72B(+2.9%) |
Sep 2001 | - | $13.33B(+7.6%) |
Jun 2001 | - | $12.39B(-9.4%) |
Mar 2001 | - | $13.67B(+1.0%) |
Dec 2000 | $13.54B(+59.3%) | $13.54B(+5.5%) |
Sep 2000 | - | $12.83B(-2.3%) |
Jun 2000 | - | $13.14B(-1.2%) |
Mar 2000 | - | $13.30B(+56.3%) |
Dec 1999 | $8.50B(+24.1%) | $8.50B(+19.0%) |
Jun 1999 | - | $7.15B(+4.2%) |
Dec 1998 | $6.86B(+6.5%) | $6.86B(+16.4%) |
Jun 1998 | - | $5.89B(-8.5%) |
Dec 1997 | $6.44B(-8.8%) | $6.44B(-8.8%) |
Dec 1996 | $7.06B(-16.7%) | $7.06B(+39.7%) |
Dec 1995 | $8.48B(+158.4%) | - |
Jun 1995 | - | $5.05B(+54.0%) |
Jun 1994 | $3.28B(-1.1%) | $3.28B(-1.1%) |
Jun 1993 | $3.32B(+11.4%) | $3.32B(+11.4%) |
Jun 1992 | $2.98B(-9.4%) | $2.98B(-9.4%) |
Jun 1991 | $3.29B(+34.2%) | $3.29B(+34.2%) |
Jun 1990 | $2.45B(+83.2%) | $2.45B(+83.2%) |
Jun 1989 | $1.34B(-9.9%) | $1.34B(-9.9%) |
Jun 1988 | $1.48B(+29.7%) | $1.48B(+29.7%) |
Jun 1987 | $1.14B(+33.8%) | $1.14B(+33.8%) |
Jun 1986 | $855.56M(+52.6%) | $855.56M |
Jun 1985 | $560.59M(+1.2%) | - |
Jun 1984 | $553.91M | - |
FAQ
- What is GSK plc annual total current liabilities?
- What is the all time high annual current liabilities for GSK plc?
- What is GSK plc annual current liabilities year-on-year change?
- What is GSK plc quarterly total current liabilities?
- What is the all time high quarterly current liabilities for GSK plc?
- What is GSK plc quarterly current liabilities year-on-year change?
What is GSK plc annual total current liabilities?
The current annual current liabilities of GSK is $27.23B
What is the all time high annual current liabilities for GSK plc?
GSK plc all-time high annual total current liabilities is $35.91B
What is GSK plc annual current liabilities year-on-year change?
Over the past year, GSK annual total current liabilities has changed by +$386.65M (+1.44%)
What is GSK plc quarterly total current liabilities?
The current quarterly current liabilities of GSK is $27.92B
What is the all time high quarterly current liabilities for GSK plc?
GSK plc all-time high quarterly total current liabilities is $45.95B
What is GSK plc quarterly current liabilities year-on-year change?
Over the past year, GSK quarterly total current liabilities has changed by +$2.21B (+8.58%)